Psilocybin induces spatially constrained alterations in thalamic functional organization and connectivity
Using a novel data-sparing ICA to subdivide the thalamus in resting-state fMRI, the study found that psilocybin produces spatially localised alterations in intrathalamic organisation—principally in the mediodorsal and pulvinar nuclei—that alter thalamocortical connectivity with visual and default-mode networks and correlate with subjective effects. These focal decreases, which may offset modest widespread increases detected by whole-thalamus analyses, were not apparent when the thalamus was treated as a single unit.
Authors
- Roland Griffiths
- Frederick Barrett
Published
Abstract
Background
Serotonin 2A receptor (5-HT 2AR ) agonist psychedelics including psilocybin and LSD (“classic” psychedelics) evoke acute alterations in perception and cognition. Altered thalamocortical connectivity has been proposed to underlie these effects, which is supported by some functional MRI (fMRI) studies. Likely due to sample size limitations, these studies have treated the thalamus as a unitary structure, despite known differential 5-HT 2AR expression and functional specificity of different intrathalamic nuclei. Independent Component Analysis (ICA) has been employed to generate functional subdivisions of the thalamus from resting state fMRI (rsfMRI) data. This report utilizes a novel data-sparing ICA approach in order to examine psilocybin-induced changes in intrathalamic functional organization and thalamocortical connectivity.
Methods
Baseline rsfMRI data (n=38) was utilized to generate a template, which was then applied in a novel ICA-based analysis of the acute effects of psilocybin on intra- and extra-thalamic functional organization and connectivity in a smaller sample (n=18). Correlations with subjective reports of drug effect and comparisons with a previously reported analytic approach (treating the thalamus as a single functional unit) were conducted.
Results
Several intrathalamic components showed significant psilocybin-induced alterations in intrathalamic spatial organization, largely localized to the mediodorsal and pulvinar nuclei, and correlated with reported subjective effects. These same components demonstrated alterations in thalamocortical connectivity, largely with visual and default mode networks. Analysis in which the thalamus is treated as a singular unitary structure showed an overall numerical increase in thalamocortical connectivity, consistent with previous literature using this approach, but this increase did not reach statistical significance.
Conclusions
Utilization of a novel analytic approach demonstrated changes in intra- and extra-thalamic functional organization and connectivity of intrathalamic nuclei and cortical networks known to express the 5-HT 2AR . Given that these changes were not observed using whole-thalamus analyses, it seems that psilocybin may cause widespread but modest increases in thalamocortical connectivity that are offset by strong focal decreases in functionally relevant intrathalamic nuclei.
Research Summary of 'Psilocybin induces spatially constrained alterations in thalamic functional organization and connectivity'
Introduction
Classic serotonergic psychedelics such as psilocybin produce profound alterations in perception and cognition that are thought to be mediated largely via serotonin 2A receptors (5-HT2AR). While most human neuroimaging studies to date have emphasised cortical 5-HT2AR-rich regions, the thalamus also expresses 5-HT2AR and is a central hub in cortico‑striato‑thalamo‑cortical circuits implicated in both psychosis and altered perceptual states. Previous functional MRI studies of psychedelics have reported mixed findings regarding thalamic function and thalamocortical connectivity, and those studies typically treated the thalamus as a single unit despite well‑known nuclei‑specific structure and function. Gaddis and colleagues set out to examine whether acute psilocybin alters the internal functional organisation of the thalamus and nucleus‑specific thalamocortical connectivity. To do so they applied a data‑sparing, template Independent Component Analysis (tICA) approach to resting‑state fMRI that leverages population priors to generate reliable, subject‑level intrathalamic components, then compared intrathalamic spatial engagement and thalamocortical connectivity between placebo and an acute 10 mg/70 kg psilocybin condition. The study also tested associations between these neural changes and concurrent subjective effects reported by participants.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- Compounds
- Topics
- Authors
- APA Citation
Gaddis, A., Lidstone, D. E., Nebel, M. B., Griffiths, R., Mostofsky, S. H., Mejia, A., & Barrett, F. (2022). Psilocybin induces spatially constrained alterations in thalamic functional organization and connectivity. https://doi.org/10.1101/2022.02.28.482395
References (24)
Papers cited by this study that are also in Blossom
Barrett, F. S., Carbonaro, T. M., Hurwitz, E. et al. · Psychopharmacology (2018)
Barrett, F. S., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2015)
Barrett, F. S., Krimmel, S. R., Griffiths, R. R. et al. · NeuroImage (2020)
Barrett, F. S., Preller, K. H., Kaelen, M. · International Review of Psychiatry (2018)
Brown, R. T., Nicholas, C. R., Cozzi, N. V. et al. · Clinical Pharmacokinetics (2017)
Carhart-Harris, R. L., Erritzoe, D., Williams, T. et al. · PNAS (2012)
Carhart-Harris, R. L., Leech, R., Erritzoe, D. et al. · Schizophrenia Bulletin (2012)
Doss, M. K., Madden, M. B., Gaddis, A. et al. · Brain (2021)
Geyer, M. A., Vollenweider, F. X. · Trends in Pharmacological Sciences (2008)
Griffiths, R. R., Johnson, M. W., Richards, W. A. et al. · Journal of Psychopharmacology (2017)
Show all 24 referencesShow fewer
Griffiths, R. R. · Journal of Psychopharmacology (2008)
Johnson, M. W., Hendricks, P. S., Barrett, F. S. et al. · Pharmacology and Therapeutics (2019)
Johnson, M. W., Richards, W. A., Griffiths, R. R. · Journal of Psychopharmacology (2008)
Kometer, M., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)
López-Giménez, J. F., González-Maeso, J. · Current Topics in Behavioral Neurosciences (2017)
MacLean, K. A., Leoutsakos, J. S., Johnson, M. W. et al. · Journal for the Scientific Study of Religion (2012)
Müller, F., Dolder, P. C., Schmidt, A. et al. · NeuroImage (2018)
Lenz, C., Dolder, P. C., Lang, U. E. et al. · Acta Psychiatrica Scandinavica (2017)
Preller, K. H., Burt, J. B., Adkinson, B. et al. · eLife (2018)
Preller, K. H., Burt, J. B., Adkinson, B. et al. · Biological Psychiatry (2020)
Preller, K. H., Razi, A., Zeidman, P. et al. · PNAS (2019)
Tagliazucchi, E., Roseman, L., Kaelen, M. et al. · Current Biology (2016)
Vollenweider, F. X., Preller, K. H. · Nature Reviews Neuroscience (2020)
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A. et al. · NeuroReport (1998)
Cited By (2)
Papers in Blossom that reference this study
Girn, M., Rosas, F. E., Daws, R. E. et al. · Trends in Cognitive Sciences (2023)
Stoliker, D., Egan, G. F., Friston, K. J. et al. · Pharmacological Reviews (2022)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.